{"id":46966,"date":"2022-08-04T23:01:39","date_gmt":"2022-08-04T21:01:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/"},"modified":"2022-08-04T23:01:39","modified_gmt":"2022-08-04T21:01:39","slug":"premier-inc-declares-an-increase-to-quarterly-cash-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/","title":{"rendered":"Premier, Inc. Declares an Increase to Quarterly Cash Dividend"},"content":{"rendered":"
\n

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors approved a 5% increase to the company\u2019s quarterly cash dividend to $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2022, to stockholders of record as of the close of business on September 1, 2022.\n<\/p>\n

<\/a><\/p>\n

\nAbout Premier, Inc.<\/b>\n<\/p>\n

\nPremier, Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,400 U.S. hospitals and health systems and approximately 225,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier\u2019s news and investor sites on www.premierinc.com<\/a>, as well as Twitter<\/a>, Facebook<\/a>, LinkedIn<\/a>, YouTube<\/a>, Instagram<\/a> and Premier\u2019s blog<\/a> for more information about the company.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor contact:<\/b>
Angie McCabe
\n
Vice President, Investor Relations
\n
704.816.3888
\n
angie_mccabe@premierinc.com<\/a><\/p>\n

Media contact:<\/b>
Amanda Forster
\n
Vice President, Public Relations
\n
202.879.8004
\n
amanda_forster@premierinc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors approved a 5% increase to the company\u2019s quarterly cash dividend to $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2022, to stockholders of record … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46966","6":"format-standard","7":"category-industry"},"yoast_head":"\nPremier, Inc. Declares an Increase to Quarterly Cash Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Premier, Inc. Declares an Increase to Quarterly Cash Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors approved a 5% increase to the company\u2019s quarterly cash dividend to $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2022, to stockholders of record ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-04T21:01:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220804005955\/en\/774286\/21\/PR_LogoSpec_%282%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Premier, Inc. Declares an Increase to Quarterly Cash Dividend\",\"datePublished\":\"2022-08-04T21:01:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/\"},\"wordCount\":228,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005955\\\/en\\\/774286\\\/21\\\/PR_LogoSpec_%282%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/\",\"name\":\"Premier, Inc. Declares an Increase to Quarterly Cash Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005955\\\/en\\\/774286\\\/21\\\/PR_LogoSpec_%282%29.jpg\",\"datePublished\":\"2022-08-04T21:01:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005955\\\/en\\\/774286\\\/21\\\/PR_LogoSpec_%282%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005955\\\/en\\\/774286\\\/21\\\/PR_LogoSpec_%282%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Premier, Inc. Declares an Increase to Quarterly Cash Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Premier, Inc. Declares an Increase to Quarterly Cash Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Premier, Inc. Declares an Increase to Quarterly Cash Dividend - Pharma Trend","og_description":"CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors approved a 5% increase to the company\u2019s quarterly cash dividend to $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2022, to stockholders of record ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-04T21:01:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220804005955\/en\/774286\/21\/PR_LogoSpec_%282%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Premier, Inc. Declares an Increase to Quarterly Cash Dividend","datePublished":"2022-08-04T21:01:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/"},"wordCount":228,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005955\/en\/774286\/21\/PR_LogoSpec_%282%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/","url":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/","name":"Premier, Inc. Declares an Increase to Quarterly Cash Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005955\/en\/774286\/21\/PR_LogoSpec_%282%29.jpg","datePublished":"2022-08-04T21:01:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220804005955\/en\/774286\/21\/PR_LogoSpec_%282%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220804005955\/en\/774286\/21\/PR_LogoSpec_%282%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/premier-inc-declares-an-increase-to-quarterly-cash-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Premier, Inc. Declares an Increase to Quarterly Cash Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46966"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46966\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}